Toward Personalized Theranostics: A Modular PET Platform for Antibody-Based Imaging and Therapy. [PDF]
This modular, site‐specific antibody platform enables customizable conjugates for PET imaging and therapy. Interchangeable payloads – including radiometals, cytotoxics, and fluorophores – support adaptable, multimodal applications with limited off‐target effects. In vivo, the DFO/DOTAGA bischelate immunoconjugate provided clear tumor delineation in PET/
Vivier D +16 more
europepmc +2 more sources
Design Strategies for Developing Chiral Macrocyclic Chelators as a Diagnostic Tool. [PDF]
Zhu Y, Law GL.
europepmc +1 more source
Exclusively Chemoselective <i>S</i>‑Acylation for Peptide Radiolabeling Using [<sup>18</sup>F]Fluoronicotinic Acid 4‑Nitrophenyl Ester as a Prosthetic Compound. [PDF]
Nwaenie N +6 more
europepmc +1 more source
<sup>131</sup>I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy. [PDF]
Zhang C +7 more
europepmc +1 more source
Fully Automated Azeotropic Drying-Free Synthesis of [<sup>18</sup>F]SynVesT-1 via Copper-Mediated Fluorination Using the Trasis All-in-One Module. [PDF]
Basuli F, Shi J, Zhang X, Swenson RE.
europepmc +1 more source
Development of an automated radiosynthesis for [<sup>68</sup>Ga]Ga-NODAGA[40Lys]-Exendin-4 in sodium acetate buffer. [PDF]
Ragot M +10 more
europepmc +1 more source
High-yield reactor production of terbium-161 using thin-layer gadolinium-160 targets, simplified chloride based separation and radiolabeling of DOTA based ligands. [PDF]
Khatoon S, Javed A, Khan Q, Abbas K.
europepmc +1 more source
FAP-Inhibitor Homodimers with Engineered Linker-Spacer Units: Toward Optimized Radiopharmaceuticals. [PDF]
Kumar N +7 more
europepmc +1 more source
In Vivo Imaging of a Photoactivatable Platinum Prodrug by Metal-Centered Radiolabeling. [PDF]
Firth G +8 more
europepmc +1 more source
Evaluation of <sup>89</sup>Zr-DFO Functionalized Manganese-Iron Oxide Core-Shell Nanoparticles as a HER2-Targeted Multimodal Imaging Candidate Nanoplatform. [PDF]
Özel D +3 more
europepmc +1 more source

